RxSight (RXST)
RxSight on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as ophthalmic goods.
4.1M
Short interest
settlement 2026-09-30
4.6
Days to cover
-0.9 days vs prior
26.9%
Short share of volume
2026-10-09
1,918
Fails to deliver
settlement 2026-09-11
Wed 4 Nov
Next earnings
estimated date
-$118K
Insider flow, 90 days
0 buys, 4 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in RXST is 4,087,921 shares, up 212,247 shares over the last month. Over the last 48 readings it ranged from 2,193,075 shares (15 October 2024) to 6,225,276 shares (31 July 2025). At the reported average volume of 883K shares a day that is 4.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rxst" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 4,087,921 | +2.8% | 882,847 | 4.63 |
| 2026-09-15 | 3,975,689 | +2.6% | 720,435 | 5.52 |
| 2026-08-31 | 3,875,674 | -9.0% | 837,879 | 4.63 |
| 2026-08-14 | 4,260,075 | +5.0% | 942,455 | 4.52 |
| 2026-07-31 | 4,056,607 | +5.6% | 1,005,206 | 4.04 |
| 2026-07-15 | 3,841,752 | -30.3% | 1,381,492 | 2.78 |
| 2026-06-30 | 5,513,925 | +31.9% | 1,602,938 | 3.44 |
| 2026-06-15 | 4,179,967 | +0.2% | 1,080,988 | 3.87 |
| 2026-05-29 | 4,171,123 | -14.0% | 695,283 | 6.00 |
| 2026-05-15 | 4,852,407 | -12.9% | 804,950 | 6.03 |
| 2026-04-30 | 5,572,193 | -0.0% | 577,786 | 9.64 |
| 2026-04-15 | 5,574,578 | +10.1% | 677,642 | 8.23 |
| 2026-03-31 | 5,063,568 | -0.1% | 806,650 | 6.28 |
| 2026-03-13 | 5,066,398 | -8.4% | 710,485 | 7.13 |
| 2026-02-27 | 5,531,006 | +3.2% | 849,449 | 6.51 |
| 2026-02-13 | 5,358,739 | +29.3% | 1,142,570 | 4.69 |
| 2026-01-30 | 4,144,635 | -13.4% | 1,128,003 | 3.67 |
| 2026-01-15 | 4,783,862 | +3.9% | 1,053,602 | 4.54 |
| 2025-12-31 | 4,602,463 | +4.0% | 712,278 | 6.46 |
| 2025-12-15 | 4,424,559 | -0.4% | 868,508 | 5.09 |
| 2025-11-28 | 4,440,350 | +1.1% | 798,192 | 5.56 |
| 2025-11-14 | 4,391,715 | +14.3% | 938,759 | 4.68 |
| 2025-10-31 | 3,841,484 | -9.7% | 517,583 | 7.42 |
| 2025-10-15 | 4,256,126 | -6.1% | 748,208 | 5.69 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of RXST volume is 26.9%, down 33.6 points over the last five sessions. Over the last 30 readings it ranged from 21.3% (25 September 2026) to 70.9% (28 August 2026). The latest reading is 18.0 points below the 30-session average of 44.8%, on 128K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 34K | 128K | 26.9% | 0 |
| 2026-10-08 | 110K | 273K | 40.4% | 0 |
| 2026-10-07 | 66K | 237K | 27.9% | 0 |
| 2026-10-06 | 117K | 222K | 52.8% | 204 |
| 2026-10-05 | 39K | 111K | 35.2% | 100 |
| 2026-10-02 | 104K | 172K | 60.5% | 2,789 |
| 2026-10-01 | 67K | 151K | 44.5% | 25 |
| 2026-09-30 | 123K | 253K | 48.6% | 0 |
| 2026-09-29 | 127K | 394K | 32.2% | 600 |
| 2026-09-28 | 95K | 373K | 25.5% | 0 |
| 2026-09-25 | 75K | 355K | 21.3% | 244 |
| 2026-09-24 | 127K | 362K | 34.9% | 1,430 |
| 2026-09-23 | 133K | 222K | 60.0% | 0 |
| 2026-09-22 | 133K | 314K | 42.5% | 284 |
| 2026-09-21 | 96K | 231K | 41.7% | 81 |
| 2026-09-18 | 95K | 393K | 24.0% | 0 |
| 2026-09-17 | 166K | 389K | 42.7% | 199 |
| 2026-09-16 | 188K | 307K | 61.3% | 0 |
| 2026-09-15 | 155K | 263K | 59.0% | 184 |
| 2026-09-14 | 77K | 158K | 48.5% | 97 |
| 2026-09-11 | 90K | 161K | 56.2% | 14 |
| 2026-09-10 | 123K | 237K | 51.8% | 0 |
| 2026-09-09 | 323K | 541K | 59.7% | 0 |
| 2026-09-08 | 126K | 369K | 34.1% | 5,000 |
| 2026-09-04 | 75K | 154K | 48.8% | 0 |
| 2026-09-03 | 82K | 246K | 33.1% | 0 |
| 2026-09-02 | 72K | 235K | 30.5% | 1,712 |
| 2026-09-01 | 211K | 330K | 63.8% | 75 |
| 2026-08-31 | 376K | 579K | 65.1% | 0 |
| 2026-08-28 | 189K | 266K | 70.9% | 10,222 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in RXST is 1,918 shares, down 4,595 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (5 February 2026) to 34,775 shares (17 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 1,918 | $5.96 | $11K |
| 2026-09-10 | 6,513 | $6.33 | $41K |
| 2026-09-09 | 86 | $6.45 | $555 |
| 2026-08-24 | 2,000 | $6.25 | $13K |
| 2026-08-13 | 700 | $7.06 | $5K |
| 2026-08-06 | 1,340 | $6.29 | $8K |
| 2026-08-03 | 28 | $6.01 | $168 |
| 2026-07-23 | 34,289 | $5.39 | $185K |
| 2026-07-17 | 34,775 | $5.57 | $194K |
| 2026-07-16 | 124 | $5.25 | $651 |
| 2026-06-25 | 281 | $5.31 | $1K |
| 2026-06-24 | 481 | $5.22 | $3K |
| 2026-06-23 | 1,679 | $4.96 | $8K |
| 2026-06-15 | 362 | $4.71 | $2K |
| 2026-06-02 | 561 | $5.24 | $3K |
| 2026-05-27 | 21 | $5.99 | $126 |
| 2026-04-29 | 766 | $7.17 | $5K |
| 2026-04-23 | 502 | $7.40 | $4K |
| 2026-04-22 | 576 | $7.09 | $4K |
| 2026-04-20 | 102 | $7.61 | $776 |
| 2026-04-10 | 213 | $6.77 | $1K |
| 2026-03-31 | 182 | $6.09 | $1K |
| 2026-03-20 | 1,665 | $6.74 | $11K |
| 2026-02-13 | 26 | $7.80 | $203 |
| 2026-02-05 | 8 | $7.94 | $64 |
| 2026-01-07 | 722 | $9.99 | $7K |
| 2025-12-22 | 1,000 | $12.03 | $12K |
| 2025-12-05 | 104 | $12.49 | $1K |
| 2025-11-20 | 142 | $9.50 | $1K |
| 2025-11-03 | 2,100 | $8.79 | $18K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at RXST reported 4 open-market sells worth $118K in the last 90 days and no open-market buys. Latest filing: Weinberg Eric (See remarks) on 2026-09-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric | See remarks | Option exercise | 35K | $4.34 | $153K | 236K |
| 2026-09-02 | Weinberg Eric | See remarks | Sell | 2K | $6.96 | $14K | 200K |
| 2026-09-02 | Goldshleger Ilya | Chief Operating Officer | Sell | 2K | $6.96 | $14K | 82K |
| 2026-09-02 | Wilterding Mark | Chief Financial Officer | Sell | 8K | $6.96 | $54K | 25K |
| 2026-09-02 | Kurtz Ronald M MD | Chief Medical Officer | Sell | 5K | $6.96 | $35K | 72K |
| 2026-08-31 | Weinberg Eric | See remarks | Option exercise | 5K | price not stated in the filing | not stated | 202K |
| 2026-08-31 | Goldshleger Ilya | Chief Operating Officer | Option exercise | 5K | price not stated in the filing | not stated | 84K |
| 2026-08-31 | Wilterding Mark | Chief Financial Officer | Option exercise | 20K | price not stated in the filing | not stated | 33K |
| 2026-08-31 | Kurtz Ronald M MD | Chief Medical Officer | Option exercise | 13K | price not stated in the filing | not stated | 77K |
| 2026-06-17 | Andrews Julie | Director | Grant | 37K | price not stated in the filing | not stated | 78K |
| 2026-06-17 | Tammenoms Bakker Juliet | Director | Grant | 37K | price not stated in the filing | not stated | 85K |
| 2026-06-17 | COHEN RAYMOND W | Director | Grant | 31K | price not stated in the filing | not stated | 67K |
| 2026-06-17 | Corley Jesse Anderson | Director | Grant | 37K | price not stated in the filing | not stated | 86K |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Grant | 37K | price not stated in the filing | not stated | 75K |
| 2026-06-17 | Fountain Tamara | Director | Grant | 37K | price not stated in the filing | not stated | 73K |
| 2026-06-17 | Maniar Shweta | Director | Grant | 37K | price not stated in the filing | not stated | 55K |
| 2026-06-17 | PALMISANO ROBERT J | Director | Grant | 37K | price not stated in the filing | not stated | 78K |
| 2026-06-17 | Warner Robert Keith | Director | Grant | 37K | price not stated in the filing | not stated | 78K |
| 2026-04-17 | Goldshleger Ilya | Chief Operating Officer | Option exercise | 12K | $4.13 | $52K | 78K |
| 2026-02-28 | Gaines Scott | Chief Customer Officer | Option exercise | 6K | price not stated in the filing | not stated | 17K |
| 2026-02-28 | Gaines Scott | Chief Customer Officer | Tax withholding | 3K | $7.61 | $20K | 15K |
| 2026-02-28 | Wilterding Mark | Chief Financial Officer | Tax withholding | 8K | $7.61 | $61K | 12K |
| 2026-02-28 | Wilterding Mark | Chief Financial Officer | Option exercise | 20K | price not stated in the filing | not stated | 20K |
| 2025-09-25 | Goldshleger Ilya | See remarks | Option exercise | 8K | $4.13 | $34K | 66K |
| 2025-09-25 | Goldshleger Ilya | See remarks | Option exercise | 15K | $4.34 | $66K | 57K |
| 2025-07-31 | COHEN RAYMOND W | Director | Grant | 36K | $0.00 | $0 | 36K |
| 2025-06-03 | Corley Jesse Anderson | Director | Grant | 11K | price not stated in the filing | not stated | 49K |
| 2025-06-03 | Tammenoms Bakker Juliet | Director | Grant | 11K | price not stated in the filing | not stated | 48K |
| 2025-06-03 | Andrews Julie | Director | Grant | 11K | price not stated in the filing | not stated | 41K |
| 2025-06-03 | PALMISANO ROBERT J | Director | Grant | 11K | price not stated in the filing | not stated | 41K |
| 2025-06-03 | Maniar Shweta | Director | Grant | 11K | price not stated in the filing | not stated | 18K |
| 2025-06-03 | Warner Robert Keith | Director | Grant | 11K | price not stated in the filing | not stated | 41K |
| 2025-06-03 | Fountain Tamara | Director | Grant | 11K | price not stated in the filing | not stated | 36K |
| 2025-06-03 | LINK WILLIAM J PHD | Director | Grant | 11K | price not stated in the filing | not stated | 38K |
| 2025-06-02 | Weinberg Eric | See remarks | Option exercise | 188K | $3.93 | $739K | 195K |
| 2025-04-14 | Thunen Shelley B | See remarks | Option exercise | 8K | $4.34 | $34K | 38K |
| 2025-03-12 | Fountain Tamara | Director | Sell | 7K | $25.71 | $180K | 25K |
| 2025-01-22 | Maniar Shweta | Director | Sell | 4K | $30.87 | $109K | 7K |
| 2025-01-16 | Corley Jesse Anderson | Director | Buy | 2K | $31.13 | $55K | 3K |
| 2025-01-15 | Corley Jesse Anderson | Director | Buy | 1K | $31.19 | $45K | 1K |
| 2024-11-29 | Goldshleger Ilya | See remarks | Sell | 3K | $46.08 | $143K | 42K |
| 2024-11-29 | Goldshleger Ilya | See remarks | Option exercise | 3K | $15.08 | $47K | 45K |
| 2024-11-26 | Goldshleger Ilya | See remarks | Option exercise | 3K | $15.08 | $47K | 45K |
| 2024-11-26 | Goldshleger Ilya | See remarks | Sell | 3K | $45.88 | $142K | 42K |
| 2024-11-26 | Maniar Shweta | Director | Sell | 4K | $45.88 | $174K | 11K |
| 2024-11-22 | Goldshleger Ilya | See remarks | Sell | 3K | $45.00 | $140K | 42K |
| 2024-11-22 | Goldshleger Ilya | See remarks | Option exercise | 3K | $15.08 | $47K | 45K |
| 2024-11-18 | Goldshleger Ilya | See remarks | Sell | 3K | $45.00 | $138K | 42K |
| 2024-11-18 | Goldshleger Ilya | See remarks | Option exercise | 3K | $15.08 | $47K | 45K |
| 2024-11-18 | Goldshleger Ilya | See remarks | Sell | 33 | $45.07 | $1K | 42K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON5 Form 144 notices on file for RXST worth $194K at the prices reported; 5 in the last 90 days worth $194K. Latest: Wilterding Mark filed on 2026-09-02 to sell 7,765 shares ($54K) from 2026-09-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-02 | Wilterding MarkOfficer | 8K | $54K | 0.019% | 2026-09-02 | E-Trade Financial Corporation |
| 2026-09-02 | Weinberg EricOfficer | 2K | $14K | 0.005% | 2026-09-02 | E-Trade Financial Corporation |
| 2026-09-02 | Kurtz Ronald M MDOfficer | 5K | $35K | 0.012% | 2026-09-02 | E-Trade Financial Corporation |
| 2026-09-02 | Goldshleger IlyaOfficer | 2K | $14K | 0.005% | 2026-09-02 | E-Trade Financial Corporation |
| 2026-08-18 | RAYMOND W COHENFormer Director | 12K | $76K | 0.029% | 2026-08-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON12 holders report 5% or more of RXST in their latest filing, all on Schedule 13G (passive). The largest reported stake is Millennium Management LLC at 7.3% of the class (3,030,287 shares), filed 2026-08-04 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-19 | 13G | Point72 Asset Management, L.P.partnership | 2.5M | 6.0% | 2026-08-12 |
| 2026-08-19 | 13G | Point72 Capital Advisors, Inc.corporation | 2.5M | 6.0% | 2026-08-12 |
| 2026-08-19 | 13G | Steven A. Cohenindividual | 2.5M | 6.0% | 2026-08-12 |
| 2026-08-04 | 13G/Ano. 2 | Millennium Management LLCother entity | 3.0M | 7.3% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 2 | Millennium Group Management LLCother entity | 3.0M | 7.3% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 2 | Israel A. Englanderindividual | 3.0M | 7.3% | 2026-06-30 |
| 2026-07-17 | 13G | BlackRock Portfolio Management LLCparent holding company | 3.0M | 7.2% | 2026-06-30 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Asset Management Inc.parent holding company | 2.1M | 5.0% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Holdings LPparent holding company | 2.1M | 5.0% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Investments GP LLCparent holding company | 2.1M | 5.0% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 1 | Artisan Partners Limited Partnershipinvestment adviser | 2.1M | 5.0% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 2 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-14 | 13G/Ano. 3 | RA Capital Management, L.P.investment adviser, partnership | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | Peter Kolchinskyparent holding company, individual | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | Rajeev Shahparent holding company, individual | 0 | 0.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 3 | RA Capital Healthcare Fund, L.P.partnership | 0 | 0.0% | 2025-09-30 |
| 2025-10-17 | 13G/Ano. 2 | BlackRock, Inc.parent holding company | 2.4M | 5.8% | 2025-09-30 |
13F holders
Tracked managers holding RXST at their latest 13F. JSON7 of the 30 tracked managers held RXST at their latest 13F, $44.9M in total at quarter-end prices. Millennium Management is the largest at $14.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 3.0M | $14.6M | 0.01% | +971K |
| D. E. Shaw & Co. | 2026-06-30 | 2.0M | $9.6M | 0.00% | +25K |
| AQR Capital Management | 2026-06-30 | 1.5M | $7.4M | 0.00% | +898K |
| Two Sigma Investments | 2026-06-30 | 1.1M | $5.5M | 0.00% | -153K |
| Point72 Asset Management | 2026-06-30 | 778K | $3.8M | 0.00% | +45K |
| Citadel Advisors | 2026-06-30 | 701K | $3.4M | 0.00% | -418K |
| Renaissance Technologies | 2026-06-30 | 141K | $678K | 0.00% | +80K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
RxSight in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows RxSight (RXST), SEC CIK 1111485, listed on Nasdaq, classified by the SEC as ophthalmic goods. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-19.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1111485Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as ophthalmic goods
Other company pages
Datasets
Frequently Asked Questions
How much of RXST is sold short?
What is RXST's daily short volume?
Does RXST have fails to deliver?
Are RXST insiders buying or selling?
Have RXST insiders filed to sell?
Who owns 5% or more of RXST?
Which tracked 13F managers own RXST?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.